BANEOCIN

This brand name is authorized in Austria, Estonia, Lithuania, Romania, Singapore

Active ingredients

The drug BANEOCIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Neomycin UNII 057Y626693 - NEOMYCIN SULFATE

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. Read about Neomycin

2 Bacitracin UNII 89Y4M234ES - BACITRACIN ZINC

Read about Bacitracin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06AX	Other antibiotics for topical use	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use
Discover more medicines within D06AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1019483, 1019494, 1869981
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010624, 1015317, 1078459, 1081605, 1085788, 1085790, 1086100, 1087703, 1087812, 1088349
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100241841
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W41668001, W41668002, W41669001
Country: SG	Health Sciences Authority	Identifier(s): 00676P, 00678P